Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fgene.2020.617174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- METTL4 is an snRNA m6Am methyltransferase that regulates RNA splicing
- (2020) Hao Chen et al. CELL RESEARCH
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
- (2020) Ya‐Ru Miao et al. Advanced Science
- Spathial: an R package for the evolutionary analysis of biological data
- (2020) Erika Gardini et al. BIOINFORMATICS
- The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112
- (2019) Nhan van Tran et al. NUCLEIC ACIDS RESEARCH
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- N6-methyladenosine links RNA metabolism to cancer progression
- (2018) Dongjun Dai et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- plotROC: A Tool for Plotting ROC Curves
- (2017) Michael C. Sachs Journal of Statistical Software
- PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes
- (2017) Yayi He et al. MEDICAL SCIENCE MONITOR
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors
- (2017) Keiichi Ohshima et al. Scientific Reports
- Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
- (2016) Zhong-Yi Dong et al. CLINICAL CANCER RESEARCH
- Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
- (2016) Jessica J. Lin et al. Journal of Thoracic Oncology
- The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
- (2016) Shuibin Lin et al. MOLECULAR CELL
- Combined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes
- (2015) Sandrine Caburet et al. BMC CANCER
- Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
- (2015) Julien Mazières et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
- (2014) S.-H. I. Ou et al. ANNALS OF ONCOLOGY
- International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women
- (2014) J. Lortet-Tieulent et al. LUNG CANCER
- Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
- (2014) Seung Eun Lee et al. MODERN PATHOLOGY
- Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach
- (2014) Le Kang et al. STATISTICS IN MEDICINE
- A worldwide trend of increasing primary adenocarcinoma of the lung
- (2013) Haruhiko Nakamura et al. SURGERY TODAY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Long non-coding RNAs in cancer progression
- (2012) Keiko Tano et al. Frontiers in Genetics
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
- (2011) H. Okayama et al. CANCER RESEARCH
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
- (2010) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
- (2009) Shuta Tomida et al. JOURNAL OF CLINICAL ONCOLOGY
- Random survival forests
- (2008) Hemant Ishwaran et al. Annals of Applied Statistics
- Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
- (2008) Lawrence Fong et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started